AbbVie, Inc.
(NYSE : ABBV)

( )
ABBV PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson
-1.41%132.800.6%$604.68m
PFEPfizer Inc.
0.27%33.240.8%$578.38m
MRKMerck & Co., Inc.
-0.40%62.170.6%$489.72m
BMYBristol-Myers Squibb Company
0.36%57.881.4%$404.91m
ABBVAbbVie, Inc.
-0.31%71.532.1%$346.03m
LLYEli Lilly and Company
-0.15%78.141.0%$314.45m
AZNAstraZeneca PLC Sponsored ADR
0.22%29.141.3%$170.78m
GSKGlaxoSmithKline plc Sponsored ADR
0.49%39.320.2%$114.98m
NVSNovartis AG Sponsored ADR
-0.28%83.280.2%$104.69m
NVONovo Nordisk A/S Sponsored ADR Class B
-1.78%45.330.1%$85.77m
SNYSanofi Sponsored ADR
-0.48%48.230.2%$44.64m
LCILannett Company, Inc.
2.89%16.0538.7%$10.61m
SCMPSucampo Pharmaceuticals, Inc. Class A
-0.89%11.1514.4%$6.11m
AKTXAkari Therapeutics Plc Sponsored ADR
-7.81%3.542.2%$0.18m
EPIXESSA Pharma Inc
-4.19%0.320.0%$0.02m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company. It engages in the discovery, development, manufacture and sale of a broad line of proprietary pharmaceutical products. The company focused on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology and dermatology; oncology, including blood cancers; virology, including hepatitis C and human immunodeficiency virus; neurological disorders, such as Parkinson's disease; metabolic diseases, including thyroid disease and complications associated with cystic fibrosis; as well as other serious health conditions. The company was founded on January 1, 2013 and is headquartered in North Chicago, IL.